5055 High efficacy of the combination of oral vinorelbine (NVBo), capecitabine (X) and trastuzumab (H) in HER2-positive metastatic breast cancer (MBC): updated results of an international phase II trial with a median follow-up of 39 months

✍ Scribed by A. Chan; V. Ganju; D. Becquart; P.F. Conte; L. Petruzelka; M. Gil-Gil; M. Morand; N. Vaissiere; G. Villanova; N. Tubiana-Mathieu

• Book ID: 119600705
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 50 KB
• Volume: 7
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(09)70947-4